Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Doctor’s Doubts Imperil Lucrative Diabetes Drugs
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
Submitted by
admin
on May 30, 2013 - 4:51pm
Source:
NY Times, NY
News Tags:
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
Headline:
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
Do Not Allow Advertisers to Use My Personal information
